Additionally, Loeser et al. [20] found that elevated serum LPS and osteopontin levels are associated with increased pain in obesity-linked OA, underscoring the impact of systemic inflammation on disease progression. Here, SPP1 is linked to obesity due to melanocortin 4 receptor deficiency.